logo
Jefferies Trims SentinelOne (S) Price Target, Maintains Buy Rating

Jefferies Trims SentinelOne (S) Price Target, Maintains Buy Rating

Yahoo3 hours ago

SentinelOne, Inc. (NYSE:S) is one of . Jefferies analyst Joseph Gallo has lowered the firm's price target on SentinelOne, Inc. (NYSE:S) to $23 from $25, while maintaining a Buy rating on the shares. The adjustment reflects a broader reduction in price targets across Jefferies' U.S. software coverage, prompted by recent multiple compression and early signs of softening macroeconomic conditions affecting deal-making in the technology sector.
Gallo pointed out that these factors could lead to what he describes as another 'mullet' year for software companies, characterized by a challenging first half followed by a stronger second half. Despite this outlook, Jefferies has not yet lowered its earnings estimates for SentinelOne, choosing instead to await further data from upcoming first-quarter checks. The analyst also noted that SentinelOne's recent guidance assumed no significant improvement in market conditions, underscoring the cautious tone from management. As uncertainty continues, many investors appear to be holding back, adopting a wait-and-see approach to gauge how the evolving environment will affect technology spending and deal activity. While the cautious stance has led to a tempered near-term outlook, Jefferies remains positive on SentinelOne's longer-term prospects, keeping a Buy rating on the stock. While we acknowledge the potential of S to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than S and that has 100x upside potential, check out our report about this cheapest AI stock.READ NEXT: 10 Best Small Cap Tech Stocks With Biggest Upside Potential and . Disclosure: None.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Walmart's (NYSE:WMT) Dividend Will Be $0.235
Walmart's (NYSE:WMT) Dividend Will Be $0.235

Yahoo

time3 minutes ago

  • Yahoo

Walmart's (NYSE:WMT) Dividend Will Be $0.235

Walmart Inc.'s (NYSE:WMT) investors are due to receive a payment of $0.235 per share on 2nd of September. Even though the dividend went up, the yield is still quite low at only 1.0%. This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality. If it is predictable over a long period, even low dividend yields can be attractive. Before making this announcement, Walmart was easily earning enough to cover the dividend. This means that most of its earnings are being retained to grow the business. Over the next year, EPS is forecast to expand by 44.4%. Assuming the dividend continues along recent trends, we think the payout ratio could be 27% by next year, which is in a pretty sustainable range. View our latest analysis for Walmart The company has an extended history of paying stable dividends. The annual payment during the last 10 years was $0.653 in 2015, and the most recent fiscal year payment was $0.94. This means that it has been growing its distributions at 3.7% per annum over that time. Dividends have grown relatively slowly, which is not great, but some investors may value the relative consistency of the dividend. Some investors will be chomping at the bit to buy some of the company's stock based on its dividend history. Walmart has impressed us by growing EPS at 6.0% per year over the past five years. A low payout ratio and decent growth suggests that the company is reinvesting well, and it also has plenty of room to increase the dividend over time. In summary, it is always positive to see the dividend being increased, and we are particularly pleased with its overall sustainability. Distributions are quite easily covered by earnings, which are also being converted to cash flows. All in all, this checks a lot of the boxes we look for when choosing an income stock. Investors generally tend to favour companies with a consistent, stable dividend policy as opposed to those operating an irregular one. Still, investors need to consider a host of other factors, apart from dividend payments, when analysing a company. For instance, we've picked out 2 warning signs for Walmart that investors should take into consideration. Looking for more high-yielding dividend ideas? Try our collection of strong dividend payers. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Kaplan Fox Encourages Investors of Hims & Hers Health, Inc. (HIMS) to Contact the Firm Before Lead Plaintiff Deadline on August 25, 2025
Kaplan Fox Encourages Investors of Hims & Hers Health, Inc. (HIMS) to Contact the Firm Before Lead Plaintiff Deadline on August 25, 2025

Associated Press

time3 minutes ago

  • Associated Press

Kaplan Fox Encourages Investors of Hims & Hers Health, Inc. (HIMS) to Contact the Firm Before Lead Plaintiff Deadline on August 25, 2025

NEW YORK, NY - June 28, 2025 ( NEWMEDIAWIRE ) - Kaplan Fox & Kilsheimer LLP announces that class action lawsuits have been filed against Hims & Hers Health, Inc. ('Hims & Hers' or the 'Company') (NYSE: HIMS) on behalf of investors that purchased or otherwise acquired Hims & Hers securities between April 29, 2025 and June 23, 2025 (the 'Class Period'). CLICK HERE TO JOIN THE CASE If you are an investor in Hims & Hers and have suffered losses, you may CLICK HERE to contact us. You may also contact Kaplan Fox by emailing [email protected] or by calling (646) 315-9003. DEADLINE REMINDER: If you are a member of the proposed Class, you may move the court no later than August 25, 2025 to serve as a lead plaintiff for the purported class. If you have losses we encourage you to contact us to learn more about the lead plaintiff process. You need not seek to become a lead plaintiff in order to share in any possible recovery. Hims & Hers operates a telehealth platform that connects customers to licensed healthcare professionals and offers a range of both prescription and non-prescription health and wellness products. On May 20, 2024, the Company announced the addition of GLP-1 injections to its comprehensive weight loss portfolio. Hims & Hers stated that '[p]roviding access to compounded GLP-1s means eligible customers can use medications with the same active ingredient as Ozempic(R) and Wegovy(R) without navigating the shortages and costs that are currently limiting access to the branded medications.' On April 29, 2025, Hims & Hers announced the first-step in a long-term collaboration with Novo Nordisk by providing 'a bundled offering of Novo Nordisk's FDA-approved Wegovy(R) on the Hims & Hers platform.' Then, on June 23, 2025, before the market opened, Novo Nordisk issued a press release announcing that it was terminating the collaboration with Hims & Hers, including that 'direct access to Wegovy(R) will no longer be available' to Hims & Hers, 'based on Hims & Hers deceptive promotion and selling of illegitimate, knockoff versions of Wegovy(R) that put patient safety at risk.' The press release stated that Hims & Hers 'has failed to adhere to the law which prohibits mass sales of compounded drugs under the false guise of 'personalization.'' The press release further stated '[b]ased on Novo Nordisk's investigation, the 'semaglutide' active pharmaceutical ingredients that are in the knock-off drugs sold by telehealth entities and compounding pharmacies are manufactured by foreign suppliers in China' that the 'FDA has never authorized or approved' according to a report from the Brookings Institute. Following this news, the price of Hims & Hers stock fell $22.24 per share, over 34%, to close at $41.98 per share on June 23, 2025. WHY CONTACT KAPLAN FOX - Kaplan Fox is a leading national law firm focusing on complex litigation with offices in New York, Oakland, Los Angeles, Chicago and New Jersey. With over 50 years of experience in securities litigation, Kaplan Fox offers the professional experience and track record that clients demand. Through prosecuting cases on the federal and state levels, Kaplan Fox has successfully shaped the law through winning many important decisions on behalf of our clients. For more information about Kaplan Fox & Kilsheimer LLP, you may visit our website at This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules. If you have any questions about this Notice, your rights, or your interests, please contact: CONTACT: Pamela A. Mayer KAPLAN FOX & KILSHEIMER LLP 800 Third Avenue, 38th Floor New York, New York 10022 (646) 315-9003 [email protected] Laurence D. King KAPLAN FOX & KILSHEIMER LLP 1999 Harrison Street, Suite 1560 Oakland, California 94612 (415) 772-4704 [email protected] Contacting or submitting information to Kaplan Fox & Kilsheimer LLP does not create an attorney-client relationship, nor an obligation on the part of Kaplan Fox to retain you as a client. View the original release on

Delete Every App That's On This List—‘Risks Are Too Great'
Delete Every App That's On This List—‘Risks Are Too Great'

Forbes

time6 minutes ago

  • Forbes

Delete Every App That's On This List—‘Risks Are Too Great'

You should never use these apps on your phone. Republished on June 28 with new national security warnings over use of these apps. Tens of millions of Android and iPhone users are being warned they have installed free apps that leave them at serious risk. Those users could now be sending their sensitive data to companies under the control of the Chinese government. Earlier this week, I reported on the list of iPhone and Android apps issued by the Tech Transparency Project (TTP). These are all VPNs — virtual private networks. Apps which are meant to make users safer and more secure but are doing the very opposite. 'Millions of Americans have downloaded apps that secretly route their internet traffic through Chinese companies,' TTP says. It last reported on this threat in April, and now says 'Apple and Google app stores continue to offer private browsing apps that are surreptitiously owned by Chinese companies… six weeks after they were identified.' A raft of warnings now have followed that report, urging users to delete the apps. 'The risks are too great' to keep them on your phone, warns Top10VPNs Simon Migliano. 'In light of these findings, I strongly urge users to avoid Chinese-owned VPNs altogether." For its part, Google says it is "committed to compliance with applicable sanctions and trade compliance laws. When we locate accounts that may violate these laws, our related policies or Terms of Service, we take appropriate action.' While Apple makes similar assurances, and says it enforces App Store rules but does not differentiate its handling of apps by the location of their developers. It does say where VPNs are concerned that data sharing with third parties is prohibited. vpnMentor's Lisa Taylor says this is 'no surprise,' that "China usually uses different methods to gain other countries' citizen's personal information, most of which are often covered behind a legal front.' And that 'free VPNs are perfect cover up to these kind of operations,' often recording user activity even when they say they don't. BeyondTrust's James Maude agrees. 'If you aren't paying for a product, you are the product. These VPN services are a perfect example of the hidden costs of free apps where users seeking more privacy online are potentially unknowingly feeding data to a foreign nation state out of fear their local coffee shop Wi-Fi is spying on them.' While Black Duck's Vijay Dilwale calls TTP's report 'a sobering wake-up call that VPNs, which claim to protect privacy, can pose very serious security risks, especially when their true ownership is hidden. These apps have access to all user traffic, and when handled by Chinese-based entities, the implications are well beyond individual privacy.' TTP reports that all of the VPNs it has identified "are listed as free in the app stores. But during TTP's May spot check, researchers observed that some of the VPNs offered in-app purchases on top of whatever users get with the 'free' app.' This lack of transparency, Taylor told me, 'is one of the main reasons why we do not recommend free VPNs and we are concerned that with all the content restrictions throughout the world, people are flocking to free VPNs.' Migliano says "true internet freedom and privacy depend on transparency and trust. Yet despite being made aware of glaring privacy failures and opaque corporate structures, Google and Apple continue to permit these high-risk apps on their platforms.' There are also some more serious national security concerns that have been raised. The nature of these apps on devices with obscure geographical locations and ownership is a major issue when it comes to those handling sensitive data or making their locations. Cequence Security's Randolph Barr warns 'there's no question Apple and Google can and should do more to mitigate the national security and privacy risks posed by VPN apps with undisclosed foreign ownership, particularly those tied to hostile nation-states.' Which raises a question around an added layer of app store security. 'While they have frameworks in place for data protection and transparency,' Barr told me, 'enforcement is often inconsistent or delayed, especially when developers obscure their true ownership through complex corporate structures. Conducting deeper vetting requires significant legal, technical, and geopolitical effort, something these platforms have been slow to scale.' This leaves a vacuum others may need to fill. Barr suggests the following mitigating actions, and says if they can't be handled at app store level, they must be done by organizations needing to control such risks: Deepwatch's Chad Cragle has issued the same warning. 'When owned by Chinese companies and hidden behind layers of shell companies, it becomes a serious concern. Apple advocates for protecting our privacy, yet these apps are still accessible. Google?' Cragle says 'they often allow nearly any app on their store. It's time for the platforms to take responsibility and set the example. You can't claim to prioritize privacy if you're letting other parties control the playbook. If they don't properly scrutinize these apps, they're not just passively allowing it—they're helping to create the problem. And let's be honest, this isn't just about privacy; it's about national security, too.' Here is the list of apps from TTP's report: Apple App Store: Google Play Store: The Android app vpnify is also in TTP's report, but has now relocated outside China and has contacted TTP to update its information and to be removed from the report.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store